Paid Clinical Trials Miramar
Discover 1,747 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Erchonia EVRLClinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
Sponsor:
Erchonia Corporation
Location:
Code:
NCT05291975
Conditions
Neuropathy, Diabetic
Neuropathy;Peripheral
Neuropathy, Painful
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Erchonia® EVRL™
Placebo Laser
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
FebriDx®FebriDx® Method Comparison Study Protocol
Sponsor:
Lumos Diagnostics
Location:
Code:
NCT06746259
Conditions
Acute Respiratory Infections (ARIs)
Eligibility Criteria
Sex: All
Age: 12 - 64
Healthy Volunteers: Not accepted
Interventions
Rapid point of care test to detect host immune response in ARI
SCENESSE & NB-UVBA Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients with Vitiligo
Sponsor:
Clinuvel, Inc.
Location:
Code:
NCT06109649
Conditions
Vitiligo
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Afamelanotide and NB-UVB Light
NB-UVB Light
CGB-500 with TofacitinibPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Sponsor:
CAGE Bio Inc.
Location:
Code:
NCT06810050
Conditions
Atopic Dermatitis (AD)
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
CGB-500 with 0.5% tofacitinib
CGB-500 Ointment with 1% tofacitinib
Vehicle (placebo)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TEV-56286A Study to Assess New Formulations of TEV-56286
Sponsor:
Teva Branded Pharmaceutical Products R&D LLC
Location:
Code:
NCT06911567
Conditions
Healthy Participants
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Accepted
Interventions
TEV-56286 Test
TEV-56286 Reference
NNC0487-0111A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT06542874
Conditions
Type 2 Diabetes (T2D)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NNC0487-0111 subcutanous
Placebo (NNC0487-0111 subcutanous)
NNC0487-0111 oral
Placebo (NNC0487-0111 oral)
RO7790121A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT06819891
Conditions
Moderately to Severely Active Crohns Disease
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Not accepted
Interventions
RO7790121
Placebo
TEV-53408A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Location:
Code:
NCT06625177
Conditions
Vitiligo
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
TEV-53408
OlezarsenCORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
Sponsor:
Ionis Pharmaceuticals, Inc.
Location:
Code:
NCT05681351
Conditions
Severe Hypertriglyceridemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Olezarsen